Frontlight ResearchEarly access
Not yet recruitingNo phase
Efficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures
Key facts
- Who runs it
- Fu Jen Catholic University
- Where
- Taiwan2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 150 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 31 Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- High-flow nasal cannula
- Conventional nasal cannula
- Record updated
- 16 November 2026
Who can take part
- Age
- 6 months and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Diagnosed with a simple congenital heart defect, including an atrial septal defect, ventricular septal defect, patent ductus arteriosus, or patent foramen ovale, and scheduled for an elective transcatheter closure procedure
- American Society of Anesthesiologists physical status classification I-III
- Written informed consent
Who cannot take part
- Complex congenital heart disease
- A skin condition over the chest that prevents placement of electrodes for noninvasive cardiac output monitoring
- Severe anatomical abnormalities of the upper airway
- Preprocedural severe cyanosis or hypoxemia, defined as an oxygen saturation below 90% while room air
- A contraindication to high-flow nasal cannula, as determined by the physician
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the efficacy and safety of high-flow nasal cannula oxygen therapy, compared with standard nasal cannula oxygen therapy, as respiratory support during transcatheter closure procedures for congenital heart disease under non-intubated deep sedation.
The 2 groups in the trial
- High-flow nasal cannula groupTreatment being tested
Receive high-flow nasal cannula during transcatheter closure procedures under deep sedation
Treatment: High-flow nasal cannula
- Conventional nasal cannula oxygen therapyExisting treatment, for comparison
Receive conventional nasal cannula oxygen therapy during transcatheter closure procedures under deep sedation
Treatment: Conventional nasal cannula
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures for Congenital Heart Disease
- Record updated
- 16 November 2026